Jagsonpal Pharmaceuticals Ltd

BSE: 507789

total announcements

507789.BO · 15 min delayed

BSECompany UpdateResults3h ago

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as a ....

Jagsonpal Pharmaceuticals Ltd has scheduled a conference call with analysts/investors on July 30, 2026, to discuss its Q1 FY27 financial results.

Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the unaudited Financial ....

Jagsonpal Pharmaceuticals Ltd has scheduled a board meeting on July 29, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and has closed the trading window till July 31, 2026.